This is a story from our 2017/18 annual report. Read more stories from the annual report here.

Using Vivametrica’s software, data from smartphone and wearable devices can now predict the likelihood of chronic disease and generate personalized health analytics and health scores. With these digital tools, insurers can evaluate risk without the process of medical exams, fluid draws, or lengthy questionnaires, making Vivametrica’s analysis faster, lower cost and more convenient. Through the Creative Destruction Lab (CDL) Rockies (seed-stage program for massively scalable, science-based companies), the company successfully raised a $750,000 investment round.

Learn more and apply:

With a novel device and stress-free monitoring system, m-Health Solutions is making cardiac monitoring accessible for all patients while streamlining monitoring and diagnosis for physicians. The company’s novel m-CARDS™ device provides a full-service solution for cardiac monitoring with a convenient delivery system, real-time monitoring and reliable outcomes, resulting in a faster diagnosis. It starts with a physician ordering the test for a given period of time, from 14 to 28 days. The patient then gets the diagnostic kit in the mail and easily hooks themselves up. If the patient has questions, m-Health staff provides service and support through a 1-800 phone line. Once monitoring is complete, the patient simply and conveniently mails back the device through the nearest Canada Post box.

For patients with suspected heart arrhythmia or suspected rare arrhythmias, this is a welcome change.  The commonly-used Holter Monitor can have up to a four-month waitlist and requires patients to get hooked up to the device in hospital. After the limited 24 or 48-hour test period, the device is returned to the hospital in person. In addition to being time-consuming for both the patient and physician, this process adds an administrative burden to hospital staff and isn’t convenient for those who live in rural or remote communities. The short testing period also doesn’t help patients with paroxysmal arrhythmia (arrhythmia that occurs once every couple of weeks, or even once per month and can be a stroke risk).

The benefit to the m-CARDS system is clear: patients can stay in their own community, reducing travel and time off work, in addition to caregivers’ time. The combination of the longer test period with real-time monitoring means physicians can intervene at any point.

For physicians, it’s quick and easy to onboard patients and results are read and analyzed from anywhere through a mobile technology platform. Thanks to the m-Health patient support line, there’s no change in workflow for the physician’s office.

Today, m-CARDS is fully adopted in Ontario and is used by all 14 Local Health Integration Networks (with over 28 hospitals and stroke centres and more than 3,500 referring physicians and 300 cardiologists interpreting). To date, m-Health Solutions has monitored over 81,000 patients. Alberta’s integrated health care model means that all patients, urban, rural and remote, could have equal access to mCARDS patient-centric, real-time cardiac monitoring should it get adopted. A centralized database allows for clinicians throughout the province to access patients’ diagnostic reports, further supporting more streamlined care.

m-Health Solutions has an Edmonton home at TEC Innovation District, a vibrant co-working space in the heart of downtown. Connect with us to learn more about becoming a TEC Innovation District tenant!

U of A student hopes her app will entice more people to try vegetarian dishes More…

Posted: Jun 14, 2019

A Point-of-Care Diagnostic Tool to Replace Chest X-Ray for the Diagnosis of Childhood Pneumonia

Description University of Alberta researchers have discovered a novel set of biomarkers which can be used to diagnose pneumonia in children. The biomarkers include chitinase-3-like-1 (CHI3L1), lipocalin-2 (LCN-2), C-reactive protein......

Posted: Jun 14, 2019

Novel Cell Isolation Method for Bio-engineering Artificial Cartilage

Description University of Alberta researchers have developed a new method to isolate cells from knee joint (meniscus). The isolated cells are non-contractile in nature and do not form scar tissue.......

Posted: Jun 13, 2019

Novel Composite Monolith as a New Solid Phase Extraction Material for Environmental Analysis

Description University of Alberta researchers have developed a new material of a composite silica monolith nested in sponge (SiMNS) for solid phase extraction. The application of the new SiMNS material......

Posted: May 21, 2019

Self Assembling Peptide for Activating Human Mast Cells

Description Researchers at the University of Alberta have developed a novel biomaterial that can activate the body’s own innate immune response and accelerate the wound healing process. This technology may......

Posted: May 21, 2019

An Innocuous Structured Scaffold for Prion Disease Vaccines and Antigens

Description Researchers at the University of Alberta, led by Dr. Holger Wille, have developed a novel strategy for the creation of vaccines and specific antigens for prion protein diseases. Applying......

Posted: May 21, 2019

Spine Mounted Stereotactic System

Description Demonstration of stereotactic setup. An example of a commercially-available micromanipulator is shown. The setup can accommodate any micromanipulator design. Dr. Vivian Mushahwar and her team have developed an image-guided......

Posted: May 15, 2019

Method for the Production of Z-Olefins from 1,3-Dienes

Description Dr. Rylan Lundgren has developed a process for formate-mediated production of Z-olefins (also referred to as cis-alkenes) in the presence of a rhodium-based catalyst. The process is highly selective......

Posted: Apr 3, 2019

A Novel Method to Produce Pitched Kefir for Reducing Cholesterol

Description Researchers at the University of Alberta and TEAGASC have jointly developed a pitched-based method to produce kefir (a fermented milk beverage) that when consumed reduces blood cholesterol levels. The......

Posted: Nov 5, 2018

Novel F-18 Beta-Hydroxybutyric Acid Radiotracers for PET Imaging

Description Researchers at the University of Alberta have synthesized novel beta-hydroxybutyric acid radiotracers for PET imaging using a 3 step radiosynthetic process. The compounds are designed to serve as radiofluorinated......

Posted: Nov 5, 2018

A Novel Method for CryoPreservation of Cells in Monolayers

Description Researchers at the University of Alberta have developed a novel method to cryopreserve cells while adhered in a monolayer configuration. This method can preserve cells on a substrate and......

Posted: Oct 30, 2018

Train-Triggered Alert System for Conditioning and Warning Wildlife

Description Researchers at the University of Alberta have developed a novel, inexpensive, and compact system to alert wildlife to approaching trains, increasing the time available to avoid a collision. Rail-caused......

Posted: Oct 19, 2018

New Topical Therapy for Melanoma

Description Dr. Afsaneh Lavasanifar and collaborators have developed a PCBCL–b-PEG-b-PCBCL (PolyGelTM) hydrogel formulation of silibinin which provides enhanced skin permeabiity and delayed release of silibinin under physiological conditions. In vitro......